SEC Form 4 · accession 0001213900-18-008714
DelMar Pharmaceuticals, Inc. · DMPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony Scott Praill
Officer — Chief Financial Officer
Period of report
Jun 29, 2018
Accepted (ET)
Jul 3, 2018 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498382
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 29, 2018 | J | 211 | $3.20 | A | 72,999 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
Remarks
Exhibit List: Exhibit 24.1 - Power of Attorney